← Back to Analyst Consensus 
SOPH Buy
SOPHiA GENETICS SA
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 3, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 5, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 5, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jul 20, 2026 | HC Wainwright & Co. | initiate | — → Buy | — | 44% |
| Jun 15, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| May 6, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Apr 15, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jan 26, 2026 | Guggenheim | maintain | Buy → Buy | $7 | 52% |
| Nov 10, 2025 | BTIG | maintain | Buy → Buy | $7 | 52% |
| Dec 18, 2024 | Craig-Hallum | initiate | — → Buy | $11 | 54% |
| Aug 7, 2024 | RBC Capital | maintain | Outperform → Outperform | $7 | 55% |
| Jun 27, 2024 | Guggenheim | initiate | — → Buy | $6 | 52% |
| Mar 6, 2024 | BTIG | maintain | Buy → Buy | $8 | 52% |
| Mar 6, 2024 | RBC Capital | reiterate | Outperform → Outperform | $8 | 55% |
| Jan 12, 2024 | RBC Capital | reiterate | Outperform → Outperform | $8 | 55% |
| Nov 29, 2023 | RBC Capital | initiate | — → Outperform | $8 | 55% |
| May 10, 2023 | Credit Suisse | maintain | — → Neutral | $5 | — |
| May 10, 2023 | Morgan Stanley | maintain | — → Overweight | $10 | 54% |
| Mar 8, 2023 | Morgan Stanley | maintain | — → Overweight | $11 | 54% |
| Jan 3, 2023 | BTIG | initiate | — → Buy | $6 | 52% |
| Nov 23, 2022 | Credit Suisse | initiate | — → Neutral | $2 | — |
| Nov 9, 2022 | Morgan Stanley | maintain | — → Overweight | $12 | 54% |
| Aug 10, 2022 | Morgan Stanley | maintain | — → Overweight | $13 | 54% |
| May 11, 2022 | Morgan Stanley | maintain | — → Overweight | $14 | 54% |
| Mar 16, 2022 | Morgan Stanley | maintain | — → Overweight | $17 | 54% |
| Feb 15, 2022 | Morgan Stanley | maintain | — → Overweight | $18 | 54% |
| Aug 17, 2021 | Morgan Stanley | initiate | — → Overweight | $24 | 54% |
| Aug 17, 2021 | Cowen & Co. | initiate | — → Outperform | $0 | — |
| Aug 17, 2021 | Credit Suisse | initiate | — → Outperform | $22 | — |
| Aug 17, 2021 | JP Morgan | initiate | — → Overweight | $23 | 54% |
Price Target Trend
Jun 22, 2026 Oct 26, 2026
EPS Estimates
+1y —
+1q —
0y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days